Kewaunee Scientific Corporation KEQU Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

Lifetime BrandsLCUT

——

Opko HealthOPK

——

AVT

AvantorAVTR

——

Other financials

Income statement

See full

Revenue$71.4M-7.5%

Gross profit$21.2M-11.6%

Operating income$5.2M-38.6%

Net income$3.4M-30.1%

EPS (diluted)$1.13-30.7%

Balance sheet

See full

Cash & equivalents$10.0M-42.0%

Total debt$25.3M+6.6%

Total equity$74.7M+15.9%

Total assets$178.3M-8.4%

Cash flow

See full

Operating cash flow$5.5M-42.0%

CapEx$928.0K+79.8%

Free cash flow$4.5M-49.0%

Valuation

See full

Market cap$101.96M-32.7%

Enterprise value$117.3M-26.0%

P/E10.6×-2.7×

P/S0.4×-0.3×

Profitability

See full

Gross margin28.5%-0.1pp

Operating margin5.9%-1.5pp

Net margin3.4%-1.3pp

FCF margin5.2%—

Returns & leverage

See full

Return on equity13.8%-5.3pp

Debt / equity0.3×0.0×

Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kewaunee Scientific Corporation's amortization expense related to capitalized debt issuance costs?: Kewaunee Scientific Corporation (KEQU) reported amortization expense related to capitalized debt issuance costs of $322K in Q4 2025.